Thousands More Vulnerable Adults Offered RSV Vaccine by NHS
The NHS is expanding its respiratory syncytial virus (RSV) vaccination programme this September to include adults aged 65–74 with chronic respiratory conditions or suppressed immune systems. This move follows advice from the Joint Committee on Vaccination and Immunisation (JCVI) to protect those at a higher risk of severe outcomes from RSV infection, including hospitalisation, particularly … Read more
